Wellington Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Buy
12,979
+820
+7% +$838K 4.12% 6
2026
Q1
$11.2M Buy
12,159
+508
+4% +$515K 3.45% 9
2025
Q4
$12.5M Buy
+11,651
New +$11.1M 4.17% 7

Other funds holding LLY

Wellington Group's LLY Position: Q2 2026 in Review

Wellington Group increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $838K and bringing the position to 12,979 shares worth $15.6M. The position accounts for 4.12% of the portfolio, ranked #6.

Wellington Group first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wellington Group held 12,979 shares of Eli Lilly worth $15.6M as of Q2 2026.
  • Wellington Group bought 820 Eli Lilly shares in Q2 2026, an estimated $838K.
  • Eli Lilly made up 4.12% of Wellington Group's portfolio in Q2 2026, its #6 holding.
  • Wellington Group first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wellington Group's 13F filing for Q2 2026, filed 14 Aug 2026.